Advisors Preferred’s Innoviva INVA Stock Holding History

Advisors Preferred’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,088	Closed	-$12K	–	240
2016 Q4	$12K	Buy	+1,088	New	+$11.4K	0.01%	175

Other funds holding INVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advisors Preferred's INVA Position: Q1 2017 in Review

Advisors Preferred sold out of Innoviva (INVA) in Q1 2017, closing a stake of 1,088 shares — an estimated $12K sold.

Advisors Preferred first reported a position in INVA in Q4 2016 and held it in 1 quarter. The position peaked at $12K in Q4 2016. 164 funds tracked by Wall St. Rank hold INVA as of Q1 2017.

Advisors Preferred reported no remaining Innoviva position as of Q1 2017 after selling out during the quarter.
Advisors Preferred sold 1,088 Innoviva shares in Q1 2017, an estimated $12K.
Advisors Preferred first reported a position in Innoviva in Q4 2016 and held it in 1 quarter.
Advisors Preferred's Innoviva position peaked at $12K in Q4 2016.
164 funds tracked by Wall St. Rank held Innoviva as of Q1 2017.

Based on Advisors Preferred's 13F filing for Q1 2017, filed 3 May 2017.